The geometric mean sVNT levels rose from 77.7% to 86.5% at pre-dose 4 and 1 month post-dose 4, respectively, albeit this did not reach statistical significance.
← all excerpts
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases.
1
—
—